FOLH1 and pachyonychia congenita: Consisting of PSMA- and SSTR-RADS, the MI-RADS frameworks are based on a five-point scale (from 1 = no evidence of disease and definitively benign to 5 = high certainty that either PC or NET are present), and indicate the site of disease and intensity of radiotracer uptake.